Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 143 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1421 8.3 months NSCLC 5 Chemotherapy
University Hospital Gasthuisberg Belgium 8/2007
Treatment Details: Patients: This phase II study involved 165 patients with stage III/IV or metastatic recurrent non-small-cell lung cancer. All had previously received a platinum-based therapy and about hal
 
1422 8.3 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
Commonwealth Cancer Center United States 2/2006
Treatment Details: Patients: This Phase II study involved 44 patients (15 men, 29 women, median age 63) with advanced non-small-cell lung cancer, of whom 36 completed the study. A subset of the 36 patients s
 
1423 8.2 months Metastatic rcc 4 Biologic therapy
Royal Marsden Hospital United Kingdom 2/2006
Treatment Details: Patients: This phase II study involved 60 patients with metastatic renal cell carcinoma (RCC). Treatment: Patients were randomized to receive thalidomide (29 patients) or medroxypro
 
1424 8.2 months NSCLC 4 Chemotherapy
Soonchunhyang University Cheonan Hospital Korea 3/2011
Treatment Details: Patients: This phase II study involved 28 patients with advanced non-small-cell lung cancer, 71.4% of whom were male. The median patient age was 63 years. Treatment: Patients were trea
 
1425 8.2 months Malignant Pleural Mesothelioma 4 Chemotherapy
Erasmus Medical Center Netherlands 4/2002
Treatment Details: Patients: This Phase II study involved 27 patients with malignant pleural mesothelioma. None of these patients had been administered prior chemotherapy. Treatment: The treatment consiste
 
1426 8.2 months Advanced NSCLC 2 Immunotherapy
Hermanos Ameijeiras Hospital Cuba 3/2003
Treatment Details: Patients: This study involved 40 patients with advanced (stage IIIb or IV) non-small-cell lung cancer. The average age of all patients was 62 years. Treatment: The treatment consisted of
 
1427 8.2 months Metastatic or relapsed NSCLC 5 Chemotherapy
Centre Hospitalier Lyon-Sud Italy 12/2002
Treatment Details: Patients: This Phase III trial involved a total of 259 patients with metastatic or relapsed non-small cell lung cancer. Patients were divided into two groups: Group A comprised of 133 patie
 
1428 8.2 months Advanced NSCLC 4 Chemotherapy
University of Palermo Italy 2/2003
Treatment Details: Patients: This Phase III study involved 278 patients with advanced (stage IIIB-IV) non-small cell cancer. (The study started with 400 patients, but two accrual groups were terminated early.
 
1429 8.2 months Advanced NSCLC 4 Chemotherapy
Hospital Germans Trias I Pujol Hospital Spain 10/2002
Treatment Details: Patients: This Phase III study involved 608 patients with advanced (stage IIIB or IV) non-small-cell lung cancer. Patients were divided into two groups. Group A contained 302 patients and
 
1430 8.2 months Recurrent GBM 4 Chemotherapy
Royal Melbourne Hospital Australia 1/2004
Treatment Details: Patients: This Phase II study involved 22 patients with recurrent glioblastoma multiforme. All patients had received radiotherapy, but only 2 had received prior chemotherapy. Treatment:
 
Page 143 of 187  | Previous Page  | Next Page